AbstrAct
Objective Bariatric surgery is the most effective intervention for weight loss and obesity-related comorbidities currently available. Little is known about adolescents entering National Health Service (NHS) bariatric programmes. We aimed to characterise those entering a pathway and report their outcomes. Design Prospective service evaluation of patients assessed within a single NHS adolescent bariatric service. results 50 patients assessed between 26 July 2007 and 27 January 2014; 6 (12%) were not eligible for surgery, 7 (14%) actively opted out, 8 (16%) were lost to follow-up and 29 (58%) underwent surgery (18 sleeve gastrectomy (SG) 11 Roux-en-y gastric bypass (RYGB) and 0 adjustable gastric band). Mean (SD) age at initial assessment was 16 .0 (1.3) years and 18.3 (1.3) at surgery (youngest 15.7 years). Mean time taken to surgery was 1.8 years; longer in those with higher body mass index (BMI) and aged below 14 at first assessment. Mean (SD) BMI at surgery was 53.1 (8. 3) kg/m 2 , lower in those undergoing RYGB (−5.2, 95% CI −11.6 to 1.13). Follow-up was inconsistent and challenging; 1/29 (3.5%) was transferred to a regional centre, 10/29 (34.5%) attended ongoing follow-up within our protocol, 6/29 (20.7%) had intermittent monitoring and 12/29 (41.4%) were lost to follow-up. Mean BMI change at 1 year (−14.0 kg/m 2 ) and complications were similar to published cohorts. Data from 11 lost to follow-up were obtained and outcomes appeared similar to those who actively followed up. conclusion Adolescent bariatric surgery in the NHS appears effective, with outcomes similar to those reported internationally. Further work is needed to optimise postsurgical surveillance and reduce age at surgery.
IntrODuctIOn
Bariatric surgery is the only intervention resulting in clinically meaningful weight loss for obese children and young people. 1 In the UK, national guidelines for adolescent bariatric surgery are contained within the most recent National Institute for Health and Care Excellence (NICE) obesity guideline. 2 The largest and most complete bariatric research cohorts come from the USA 3 4 and Sweden 5 comprising between 25 and 242 adolescents undergoing surgery, compared with very small case reports totalling 20 adolescents in the UK. [6] [7] [8] A recent systematic review of adolescent bariatric surgery showed mean loss of 13.5 kg/m 2 at 1-year postsurgery with greatest change seen in those undergoing Roux-en-Y gastric bypass (RYGB), followed by sleeve gastrectomy (SG) and adjustable gastric band.
1 Such changes are very much greater than those from with drug treatments such as metformin (mean loss 1.4 kg/m 2 ), 9 orlistat (−0.8 kg/m 2 ) 10 or lifestyle interventions (−1.25 kg/m 2 ).
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Outcome studies have mostly focused on those who received surgery, 1 with only one service in Saudi Arabia publishing pathway outcomes in a clinical service. 12 It is unclear how many young people who are referred for surgery actually receive it and the reasons for not receiving it in those referred. Furthermore, the outcomes of those entering a clinical programme compared with a research cohort are largely unknown. Such data are important for
What this study adds?
► BMI outcomes and complications in those undergoing surgery in a clinical National Health Service (NHS) bariatric service are equivalent to international cohorts, with similar complication rates and no deaths. ► Adolescents undergoing surgery in an NHS adolescent bariatric pathway were older than those in published cohorts, with longer time taken to reach surgery. ► Attrition was common and higher than seen in research cohorts. There were suggestions that low socioeconomic status influenced access to surgery. Those not attending follow-up appeared to have similar outcomes but did not have micronutrient surveillance. Home visits and telephone surveillance appear useful in research cohorts and should be considered in clinical services.
Adolescent health
Outcomes of 50 patients entering an adolescent bariatric surgery programme planning and evaluating adolescent surgery programmes, particularly within state-funded systems. Our aim was to characterise the patients referred to an adolescent bariatric surgery programme within the NHS in England and report their outcomes, including the number reaching surgery, change in BMI and complications. We present data for the first 50 patients assessed within a single service.
MethODs
We reviewed data on prospectively identified adolescent patients referred to University College London Hospitals (UCLH) for consideration of bariatric surgery. Inclusion criteria were age less than 18 years and first assessed between 1 July 2007 and 27 January 2014.
Body weight was measured using Tanita BC-418MA or SECA 645 scales, height using a wall-mounted stadiometer. BMI was calculated as weight/height 2 (kg/m 2 ) and BMI z-score (zBMI) using UK reference data. 13 We screened for diabetes using haemoglobin A1c and fasting glucose; hypertension using automated blood pressure monitor (Datascope Accutor Plus) 14 with appropriately sized cuff and UK thresholds 15 and raised lipids using American Heart Association thresholds. 16 Those having surgery had a standard oral glucose tolerance tests 17 and where clinically indicated, screening for sleep apnoea and polycystic ovarian syndrome. 18 Previous screening results were used in those who left presurgery and refused screening. All participants were invited to participate in the Genetics of Obesity Study to enable identification of monogenic causes of obesity. 19 Socioeconomic status was derived from the patient's home postcode using the 2007 Index of Multiple Deprivation (IMD, England only) and grouped into five deprivation quintiles (lowest quintile defined as 'deprived'). 20 Ethnicity was self-reported using a list used by the hospital.
We assumed lack of interest if two successive preoperative appointments were missed and we were unable to contact families by telephone or letter. All participants were reviewed by a clinical psychologist to assess Gillick competency and screen for mental health comorbidities. Eligible patients were offered choice of RYGB or SG procedure once weight gain had ceased, with those having higher BMI encouraged to undergo SG (surgeon preference due to safety concerns). We used patient records to collect BMI trajectories and comorbidity data. We attempted to contact all postoperative patients who had not attended follow-up within the previous 6 months if they were in the first two postoperative years or 1 year after that. Where we were unable to contact participants, we gathered information from their parent or general practitioner (GP; self-reported BMI not included in trajectory analyses).
Analyses
We used descriptive statistics to describe patients flow, Student's t-test and χ 2 tests to compare group differences and regression models to analyse time taken to surgery. Data nearest 1 year postsurgery were used to calculate BMI change at 1 year (8-16 months only).
study approval
This study fulfilled National Research Ethics Service criteria for service evaluation, and was registered in the UCLH Research & Development Department. Figure 1 summarises patient flow. A total of 50 patients were assessed; 7 (14%) actively withdrew from the preoperative pathway, 8 (16%) did not attend to complete assessments, 6 (12%) were deemed ineligible and 29 (58%) underwent bariatric surgery. Reasons given for active withdrawal were the wish to pursue non-surgical interventions and stress of coming into a London hospital; none were due to lack of funding. Principal reasons for exclusion were: residence outside the UK making postoperative monitoring unsafe (n=1), inability to consent due to learning difficulties (n=2), severe needle phobia (n=1), inconsistent desire to undergo bariatric surgery (n=1) and complex behavioural difficulties (n=1). None were excluded because of psychiatric disorders. One deemed ineligible subsequently underwent surgery in the private sector. Table 1 summarises demographics and comorbidities. Distance from patient home to UCLH were <10 miles in 20/50 (30%), <50 miles in 39/50 (78%) and <100 miles in 46/50 (92%). Three had hypothalamic obesity secondary to previous treatment of hypothalamic-pituitary tumours; the two with previous craniopharyngioma underwent SG but given their outcome (described below), surgery was not offered to the subsequent patient with optic glioma. One with an identified obesity-promoting monogenic genetic variant (homozygous leptin receptor mutation) and one with achondroplasia underwent surgery.
results

Preoperative patient flow
Patient characteristics
Access to surgery
There was no difference in gender, BMI or age between those having surgery and those not having (p<0.05). Deprivation data were available for 48 participants (one from Scotland, one postcode not registered on IMD). Graphically it appears that patients from more deprived populations were less likely to get to surgery (figure 2); however, there was no difference in access to surgery between those in the most deprived quintile and the remainder of the cohort.
Mean time from assessment to surgery was 1.8 years (range 0.5-4 years). All four patients entering the pathway below 14 
Adolescent health
table 1 Demographics and baseline comorbidity data for complete cohort, those undergoing surgery and those not undergoing
Weight outcomes
Follow-up postsurgery was inconsistent. At the time of analysis, patients were mean 4.0 years (SD 1.9) postsurgery (range 1.4-7.9). All were offered follow-up at our centre. One was transferred to a regional centre for ongoing follow-up. Of the remaining, 26.3% (10/28) attended ongoing follow-up within our protocol, 21.4% (6/28) had intermittent monitoring, 42.9% (12/28) were lost to follow-up and. Follow-up was achieved in 79.3% at 1 year postsurgery (23 of the 29 reaching 1 year since surgery), 59.1% at 2 years (13 of 22) and 33.3% at 5 years (3 of 9).
BMI data at 1 year were available for 23 patients (11 RYGB, 12 SG), with no evidence of difference in means between the two procedures (mean (SD) RYGB −14.8 (5.5), SG −13.4 (10.8), p=0.7). Greater variation in BMI change at 1 year was seen in patients undergoing SG than RYGB. Figure 3 shows the BMI trajectory of each patient relative to BMI at surgery. A substantial variability in BMI trajectories was seen across subjects. Data were predominantly limited to 3 years after surgery. In line with published studies, the majority of patients lost weight rapidly in the first 6 months (10-20 kg/m 2 ), with subsequent deceleration in the rate of weight loss in the next 6 months and weight stability in the second year. The patient with achondroplasia lost over 30 kg/m 2 in the first year after surgery; however, his stature makes BMI hard to interpret. Of the two patients with previous craniopharyngioma (both underwent SG), one regained all BMI loss and the other lost 23.2 kg/ m 2 after 6.3 years follow-up. Two further patients regained all Outcome data were gained from 16 of 17 participants with intermittent or inactive follow-up (eight from young person, four from parents and four from GPs); the remaining patient had no identifiable contact details or GP. None had ongoing local specialist monitoring for complications or micronutrient status. They reported BMI trajectories in the range of those attending follow-up (one GP was not aware of their patient's weight trajectory); one reported regain of all postoperative weight loss and one mother reported an unspecified amount of weight regain after removal of the Fobi ring; neither had any identified comorbidities suggesting they may respond poorly to surgery.
comorbidities and complications
No patients died postoperatively; 2/29 (6.9%) patients had a gastric perforation, one identified in the immediate postoperative period after RYGB and the second 1 year after surgery. Both were successfully repaired by laparoscopy with no further sequelae; 2/29 (6.9%) patients had a gastrojejunal stricture, both treated after respectively one and two endoscopic dilatations.
The patient with previous craniopharyngioma and subsequent cerebral vascular disease and cerebral vascular events (CVE) had a further CVE in the perioperative period resulting in haemiplegia, expressive and receptive dysphasia and loss of thirst. He required prolonged neuro-rehabilitation with residual loss of function. The following sequelae were also reported: gall stones requiring cholecystectomy (n=3), excess skin (10), pregnancy (2), gastro-oeosophageal reflux (7), unexplained abdominal pain (2), constipation(1), oesophagitis resolved after removal of Fobi ring(1), hypotension (1 postural, 1 cause unknown), ulcerative colitis with biliary cirrhosis and gastroparesis (1), poorly controlled polycystic ovarian syndrome (2), skin infections (1) and dumping syndrome (1) .
Data were insufficient to allow detailed analysis of resolution of comorbidities or cardiometabolic risk factors postoperatively, with the exception of diabetes. Diabetes control improved in all three patients with diabetes; two were able to stop all hypoglycaemic agents.
DIscussIOn
This is the first study describing the characteristics and outcomes of patients entering an adolescent bariatric surgical programme in the NHS. We found that over half of adolescents seen were both eligible and interested in surgery. Main reasons for non-eligibility were lack of capacity to consent, behavioural difficulties and inconsistent desire for surgery. Patients had relatively few identified comorbidities and surgery was undertaken mainly for weight loss rather than control of obesity-related conditions.
Change in BMI, mortality and complications were within the range described in systematic reviews. 1 21 Patients undergoing SG had a higher baseline BMI and greater variation in BMI change after surgery compared with those having a RYGB. High rates of attrition to follow-up were seen after surgery, despite earlier careful identification and support of medical and psychological comorbidities and good adherence to the preoperative preparation programme.
These data raise important issues. First, we were referred low numbers of adolescents with weight-related comorbidities that respond well to bariatric surgery, such as type 2 diabetes, sleep apnoea and idiopathic intracranial hypertension. [22] [23] [24] We hope that raised awareness of the safety and efficacy of bariatric surgery to control these conditions will increase referrals. Subsequent to this cohort, we have seen an increase in patient referrals, particularly those with type 2 diabetes.
Second, the mean age at surgery was 18 years of age and the youngest was 15.7 years. This compares with a mean age of 16.5 and 17.1 years in larger cohorts described previously. 4 5 This may reflect time taken from first assessment to surgery or reluctance to refer younger patients in the NHS. NICE guidance recommends surgery in those who have 'nearly reached physiological maturity', a conservative recommendation compared with other international guidelines. 25 Earlier referrals may help reduce the age at surgery and change the BMI trajectory of this population.
Third, we encountered various dilemmas about eligibility for surgery, particularly for those who perceived that surgery was the only remaining treatment option. A systematic review undertaken by these authors has shown that there is a limited evidence base on psychosocial predictors of outcome after surgery in adolescence, with only two studies comparing baseline psychosocial variables and BMI outcomes. 26 In addition, we reviewed three patients with previous pituitary-hypothalmic tumours. Two underwent a bariatric procedure (SG) with disappointing results. A subsequently published small case series suggest improved outcomes after RYGB compared with SG in those with hypothalamic obesity 27 ; however, small numbers and non-randomised methodology limit generalisability.
Fourth, there was significant attrition both before and after surgery. Our data suggest a non-significant trend for those with lower SES to be more likely to drop out presurgery, and it will be important to monitor and facilitate access of deprived groups to surgery. Our postoperative attrition was high compared with research cohorts who achieved follow-up rates of 89%-100% at 2 years through telephone surveillance and home visits. 4 5 28 Those not attending follow-up largely reported doing equally well as those attending follow-up, and attrition was largely due to the practicalities of attending follow-up rather than poor outcomes. Attrition has subsequently improved with the appointment of a dedicated adolescent specialist nurse who provided email, short message service and telephone monitoring in addition to standard clinic appointments. Lastly, patients frequently described issues with excess skin, with difficulty accessing plastic surgery in the NHS due to variations in funding and eligibility criteria.
